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Type 1 diabetes (T1D) is a chronic autoimmune disease that results from destruction
of pancreatic β-cells. T1D subjects were recently shown to harbor distinct intestinal
microbiome profiles. Based on these findings, the role of gut bacteria in T1D is being
intensively investigated. The mechanism connecting intestinal microbial homeostasis
with the development of T1D is unknown. Specific gut bacteria such as Bacteroides
dorei (BD) and Ruminococcus gnavus (RG) show markedly increased abundance prior
to the development of autoimmunity. One hypothesis is that these bacteria might traverse
the damaged gut barrier, and their constituents elicit a response from human islets
that causes metabolic abnormalities and inflammation. We have tested this hypothesis
by exposing human islets to BD and RG in vitro, after which RNA-Seq analysis
was performed. The bacteria altered expression of many islet genes. The commonly
upregulated genes by these bacteria were cytokines, chemokines and enzymes,
suggesting a significant effect of gut bacteria on islet antimicrobial and biosynthetic
pathways. Additionally, each bacteria displayed a unique set of differentially expressed
genes (DEGs). Ingenuity pathway analysis of DEGs revealed that top activated pathways
and diseases included TREM1 signaling and inflammatory response, illustrating the ability
of bacteria to induce islet inflammation. The increased levels of selected factors were
confirmed using immunoblotting and ELISA methods. Our data demonstrate that islets
produce a complex anti-bacterial response. The response includes both symbiotic and
pathogenic aspects. Both oxidative damage and leukocyte recruitment factors were
prominent, which could induce beta cell damage and subsequent autoimmunity.
Keywords: autoimmunity, Bacteroides dorei, β-cell, dysbiosis, Ruminococcus gnavus, type 1 diabetes

HIGHLIGHTS
- Gut dysbiosis and impaired gut permeability are features of type 1 diabetes (T1D).
- Bacteroides dorei (BD), Ruminococcus gnavus (RG) are two bacteria increased at time of onset
of T1D.
- Exposure of isolated human islets to BD or RG revealed bacteria-specific alterations in gene
expression profiles.
- The genes upregulated by both BD and RG were dominated by cytokines and chemokines
suggesting an islet antibacterial response involving subsequent recruitment of immune cells.
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same time periods were used as positive controls. To gain
insights into the mechanisms associated with the islet specific
antibacterial response, next generation sequencing (NGS) was
performed. Differentially expressed genes (DEGs) were subjected
to core analysis using Ingenuity Pathway Analysis (IPA) software.
IPA analysis revealed distinct sets of transcripts, canonical
pathways, upstream regulators, diseases, and networks specific
to each bacterium. The list of DEGs common to all bacteria
and IL-1β at both 6 and 24 h are dominated by cytokines,
chemokines, and enzymes. Our results identify unique bacteriaspecific transcriptional changes revealing both protective and
pathogenic features of the islet bactericidal response.

- Findings of our study uncovered key features of the islet
response toward invading bacteria.

INTRODUCTION
Type 1 diabetes (T1D) is a life-threatening disease with a rapidly
increasing incidence in children and adolescents (1). T1D is
thought to result from the destruction of insulin producing
pancreatic β-cells by self-reactive T cells that infiltrate the islets
(2). However, its etiology remains poorly understood. The genetic
susceptibility to T1D is associated with specific human leukocytes
antigen (HLA) alleles (3), though <10% of genetically susceptible
people develop clinical T1D (4). This variation demonstrates that
non-genetic factors, e.g., those contributed by the environment,
could play an important role in pathogenesis of the disease (5).
The gastrointestinal tract (GIT) represents the largest
compartment in the body where the host experiences the
external environment (6). Intestinal biopsies from children
with T1D revealed distinctive inflammatory changes (7).
Moreover, increased expression of inflammatory cytokines in the
duodenal mucosa of T1D patients was associated with altered
composition of the gut microbiome (dysbiosis) (8). In this regard,
several recent studies have also reported intestinal dysbiosis
in individuals with newly diagnosed T1D (9–13). Differential
abundance of certain microbial communities e.g., increased
Bacteroides and decreased short chain fatty acids (SCFA)producing bacteria, was reported as a common feature in T1D by
the aforementioned studies. Bacteroides dorei and Ruminococcus
gnavus are two bacterial species noted to be increased in
infants genetically susceptible to T1D at/before development of
autoantibodies (14, 15). An increased intestinal permeability was
also reported in children at risk for T1D (16). The disruption
of the gut epithelial barrier and subsequent leakage of microbial
products into pancreas could be a predisposing factor to T1D,
as suggested by Korsgren et al. (17). Indeed, whether bacterial
products can elicit a response within the pancreas remains largely
unknown. Costa et al. (18) noted translocation of gut bacteria to
pancreatic lymph nodes (PLNs) of streptozotocin (STZ)-injected
mice, an experimental model of T1D, by both morphological
and molecular approaches. Such translocation was thought to
contribute to the pathogenesis of T1D by activating pathogenic
T helper 1 (Th1) and Th17 cells that expanded in the PLNs
and pancreas. Despite the many advances in our knowledge of
changes in the gut microbiome during T1D progression, their
role in pathogenesis remains unknown. The intrinsic response
of human islets to specific bacteria, especially those of the gut in
T1D subjects remains unknown.
In the present study, we experimentally tested the hypothesis
that intestinal dysbiosis and leakage of bacteria into the human
pancreas could trigger an anti-bacterial immune response
from islets. To achieve that aim, isolated human islets were
exposed to Bacteroides dorei or Ruminococcus gnavus, two
bacteria overrepresented in the gut just before/at incidence
of autoimmunity in T1D susceptible individuals (14, 15)
and Escherichia coli, a ubiquitous bacterium associated with
accelerated maturation of the gut microbiome (19, 20) for 6
or 24 h. Islets exposed to the potent cytokine IL-1β for the
Frontiers in Immunology | www.frontiersin.org

MATERIALS AND METHODS
Bacterial Culture and Preparation of
Inocula
Bacteroides dorei (BD, Leibniz Institute DSMZ-German
Collection of Microorganisms and Cell Cultures Cat#
17855), Escherichia coli (EC, Invitrogen Cat# 18258012),
and Ruminococcus gnavus (RG, ATCC, Cat# 29149) were
purchased from commercial vendors and grown according to
standard protocols. Both BD and RG were grown anaerobically
in tryptic soy broth supplemented with Oxyrase (Oxyrase
Inc.) and resazurin salt (Sigma-Aldrich) while EC was grown
aerobically in Luria-Bertani broth. All bacteria were allowed
to reach early/mid-stationary phase of growth. At the end of
culture, bacteria were fixed in 4% paraformaldehyde (PFA) for
30 min, rinsed three times with sterile PBS and then reconstituted
in sterile physiological saline. To ensure all bacteria were killed,
bacterial stocks were used to inoculate additional broth. Absence
of bacterial growth 48 h after inoculation under standard
culturing conditions indicated all bacteria were killed by the
PFA exposure. For confirmation of the purity of tested bacteria,
genomic sequencing was performed for each bacterial strain
(Supplementary Table 1).

Study Subjects
Primary human cadaveric islets from eight non-diabetic
donors (21–58 years old) were ethically obtained from
Prodo Laboratories Inc (Aliso Viejo, CA, USA). The donor
characteristics are provided in Supplementary Table 2.

Culture and Viability Assessment of Islets
Upon arrival, islets were initially incubated for 6–24 h at 37◦ C
in CMRL-1066 medium (Gibco, USA) supplemented with 2 mM
l-glutamine, 1% penicillin-streptomycin, and 10% fetal bovine
serum (FBS). After that, individual donor islets were cultured in
4-well plates containing FBS-free media at 1,000 islet equivalents
(IEQs) per well. Each well was exposed to one of the three
bacterial strains at 10 bacteria per cell (BpC) for 6 or 24 h. Time
matched controls were also included using IL-1β (InvivoGen) at
1 ng/ml (positive control) and FBS-free media (negative control).
Bacteria and IL-1β concentrations were considered appropriate if
they induced significant changes in the percent of viable IEQs in
a given treatment within 24 h. In order to monitor the viability
of IEQs throughout different incubations, a dithizone (DTZ)
assay was performed according to the standard protocol from
2
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concentration were assessed using an Agilent Bioanalyzer 2100
(Agilent) and Nanodrop Spectrophotometer, respectively. After
that, cDNA libraries were generated using a SciClone NGS
Library Production Robot (Perkin Elmer) and library quality was
verified using the Agilent Bioanalyzer. RNA sequencing (RNASeq) was subsequently performed using an Illumina HiSeq2500
system (Illumina, San Diego, CA, USA) to achieve single 100
base pair reads with a read depths of 15–20 million reads per
sample. Short raw sequence reads were downloaded from the
HiSeq2500 server in FASTQ format and individually mapped
to the human reference genome (hg38) using TopHat. The
complete bioinformatics analysis pipeline for the RNAseq data
was performed using the Tuxedo protocol, which includes
TopHat, Cufflinks, Cuffmerge, and Cuffdiff (22). Differential
gene expression analysis results from the Cufflinks analysis of
individual samples were reported as Fragments Per Kilobase of
transcript per Million Mapped reads (FPKM) which reports the
normalized expression values for a given gene and accounts for
multiple reads for an individual fragment. Transcripts up- and
downregulated relative to controls were considered significantly
changed only when the false discovery rate (FDR) adjusted pvalue (q-value) was <0.05. Relative differences in gene expression
were assessed by comparing the log2-fold change values between
the islet FPKMs for bacteria-treated and time-matched controls.
For easier interpretation of obtained datasets, all log2-fold change
values were converted to their equivalent numeric values. Fastq
files and RNA-Seq processed data were deposited into the NCBI
GEO repository under the accession number GSE131320.

FIGURE 1 | Optimized bacterial and IL-1β exposures induced significant and
comparable reductions in human islet viability. (A) Aggregate viable IEQs
across all treatment conditions significantly decreased (∼20%) from the initial
(0 h) to the experimental end points. (B) No significant differences in viable IEQs
were observed in serum free controls (SFC) or between individual bacteria (BD,
B. dorei; EC, E. coli; RG, R. gnavus) exposure groups while bacteria-exposed
islets displayed reduced viabilities relative to SFC at 24 h, indicating significant,
but comparable reductions in viability across bacteria. Data are shown as
averages ± standard error of the mean. * P < 0.05. Ns, not significant.

Ingenuity Pathway Analysis and Data
Visualization

the National Institutes of Health (NIH) at the beginning and end
of each experiment (21). Islet viability was 90.2 ± 2.4% at the
onset of the exposure period and declined, on average, <20%
throughout the treatment period (Figure 1A). While there was
no significant difference between the experimental conditions
(Figure 1B), the percentage of viable IEQs significantly decreased
from the zero point to 6 h and from the 6 to 24 h. This limited, yet
significant, reduction in islet viability was essential for detecting
the changes in transcript levels in the remaining islets. At the
end of exposure, ∼500 IEQs from each condition were prepared
for RNA isolation while ∼300 IEQs were prepared for protein
extraction and subsequent western blot analysis. Supernatants
were additionally collected from each sample. All samples were
subsequently flash frozen on dry ice and stored at −80◦ C until
further use.

The obtained datasets of DEGs were filtered using cut-offs of
± 2 and 0.05 for fold change and q-value, respectively. The
generated lists of DEGs from all treatments were uploaded into
the IPA software (Ingenuity Systems, Redwood City, CA) for
core analyses. Initially, each group was analyzed separately using
default parameters for altered canonical pathways, upstream
regulators, diseases, and networks. After that, all groups were
compared with each other to elucidate both shared and unique
features induced by each treatment. Z-score is a statistical
measure of the match between expected relationship direction
and observed gene expression (23). Changes with an activation zscore ≥2 or ≤ −2 were considered significant. To show canonical
pathways with highest significant changes, the list of differentially
expressed pathways were further trimmed at p-value ≤0.05 in the
IPA software. Venn diagrams of shared and unique DEGs were
done using an online tool from Bioinformatics & Evolutionary
Genomics (24). Heat maps of DEGs common to all groups at 6
and 24 h were generated using ClustVis (25).

RNA Sequencing

Protein Extraction and Immunoblotting

A total of 42 samples [serum-free control (SFC), IL-1β6 h, and EC-6 h = 6 each and IL-1β-24 h, EC-24 h, BD6 h, BD-24 h, RG-6 h & RG-24 = 4 each] derived from six
human islet donors exposed to various treatment conditions
were analyzed using NGS. Briefly, total RNA was isolated
using Qiagen RNeasy Minikits (Qiagen) according to the
manufacturer’s recommendations. Next, RNA integrity and

Following culture, pancreatic islets were immediately rinsed
with ice-cold PBS followed by lysis with Mammalian-Protein
Extraction Reagent (M-PER, Pierce Biotechnology, MA, USA)
supplemented with Halt Protease and Phosphatase Inhibitor
cocktail (Thermo Scientific). The concentrations of the extracted
proteins were then determined with Bio-Rad total protein assay
(Bio-Rad, USA). Protein lysates were diluted in 4X Laemmli
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FIGURE 2 | Differentially expressed genes (DEGs) at 6 and 24 h by all groups. (A,E) Number of DEGs in human islets after individual bacteria or IL-1β exposure for 6
or 24 h, respectively. (B,C) Venn diagrams indicating the overlap of up- (B) and down-regulated (C) genes at 6 h in all groups. (D) Heatmap of the hierarchical
clustering of the shared DEGs at 6 h depicting their expression patterns. (F,G) Venn diagrams indicating the overlap of up- (F) and down-regulated (G) genes at 24 h in
all groups. (H) Heatmap of the hierarchical clustering of the shared DEGs at 24 h depicting their expression patterns. Genes were clustered based on log2 of their
expression values using Pearson’s correlation and complete linkage function. The color key indicates the direction of changes: red and blue depict significant up- and
down-regulation, respectively.

buffer, heated at 95◦ C for 5 min, and two micrograms of the
extracted proteins were loaded per each lane onto a 4–15%
precast polyacrylamide gel (Bio-Rad, USA) for electrophoresis
and electro-transferred to polyvinylidene difluoride (PVDF)
membranes (Thermo Scientific). The membranes were then
blocked in 5% non-fat dry milk in TBS-0.1% Tween-20 (TBST)
for 2 h at room temperature. Blocked membranes were then
incubated overnight at 4◦ C with primary antibodies against
NAMPT (dilution 1:2,000, P4D5AT, Enzo Life Sciences Inc., NY,
USA), TRAF3IP2 (1:200, sc-100647, Santa Cruz Biotechnology
Inc., CA, USA), SOD2 (1:10,000, #13141, Cell Signaling
Technology MA, USA), and GAPDH (1:10,000, sc-365062, Santa
Cruz Biotechnology). The next day the membranes were washed
three times in TBST and incubated for 1 h at room temperature
with corresponding peroxidase-conjugated secondary antibodies
(Jackson ImmunoResearch Laboratories, PA, USA) at dilution
rates of 1:40,000 for NAMPT and 1:80,000 for others. Bound
antibodies were visualized using ECL (SuperSignal West Femto
Maximum Sensitivity Substrate or SuperSignal West Pico PLUS
Chemiluminescent Substrate (Pierce Biotechnology) depending
on the expected signal strength) and recorded on X-ray
films. Immunoblots were stripped and reprobed with GAPDH
antibody, served as loading control, and the relative band
intensities were measured using the ImageJ software 1.46r
(National Institutes of Health; http://imagej.nih.gov/ij/).

were used for measuring their concentrations in islet culture
supernatants per manufacturer instructions. All samples were
assayed in duplicate.

Statistical Analysis
Graphs for western blot and ELISA were drawn using GraphPad
Prism 7 (GraphPad Software, CA, USA). The differences between
groups were determined using the ANOVA test. Post-hoc ttests were run to evaluate group-specific differences when
warranted by a significant ANOVA. P-values ≤0.05 were
considered significant.

RESULTS
Bacteria and IL-1β Induce Differential Gene
Expression in Isolated Human Islets
Gene expression profiling of human islets incubated with BD, EC,
RG, or IL-1β revealed alterations in gene expression levels at both
6 and 24 h (Figure 2, Supplementary Table 3). Among the three
tested bacteria, EC was associated with the highest number of
DEGs at 6 and 24 h (459, 310), followed by RG (305, 225), and BD
(157, 151). IL-1β treatment altered the expression of 923 and 783
genes at 6 and 24 h, respectively. These DEGs were dominated
by up-regulated transcripts common to all bacterial treatments at
both 6 and 24 h (Figures 2A,E).
Transcripts with shared and unique expression patterns
were found among the different experimental conditions at
each time point (Figures 2A–C,E–G). Different numbers of
DEGs shared by two or more treatments were also seen and
changed with increased bacteria exposure time. For instance,

Enzyme Linked Immunosorbent Assay
Sandwich ELISA kits from R&D Systems (R&D Systems Inc.,
Minneapolis, USA) for IL-8 (Cat# DY208-05), CXCL1 (Cat#
DY275-05), CCL20 (Cat# DM3A00), and CXCL6 (Cat# DGC00)
Frontiers in Immunology | www.frontiersin.org
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genes specific to both groups are found at 24 h. Heatmaps
of DEGs common to all groups at 6 and 24 h are plotted in
Figures 2D,H, respectively.

five upregulated genes are uniquely shared by BD and EC
at 6 h, but none at 24 h. Conversely, no upregulated genes
were exclusively shared by BD and RG at 6 h, though nine

FIGURE 3 | Differentially expressed canonical pathways in human islets by all treatments at 6 and 24 h. Heatmaps indicating activation z-scores for differentially
expressed canonical pathways; (A) Cellular Immune Response, (B) Cytokine Signaling, (C) Humeral Immune Response, (D) Pathogen Influenced Signaling,
(E) Cellular Stress and Injury, (F) Disease Specific Signaling, and (G) Ingenuity Toxicity List Pathways. The color key indicates the direction of changes: orange color
shows predicted overall activation of the pathway and blue color indicates predicted overall inhibition of the pathway. Only pathways with absolute z-score ≥ 2 or ≤
−2 and p-value ≤0.05 (in the IPA software) are shown. Pathways common to all treatments (underlined in green), pathways predominantly regulated by bacteria
(underlined in red), and pathways shared only by some treatments (underlined in blue) are illustrated.
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Canonical Pathways Modulated by
Bacteria and IL-1β in Human Islets

and IL-1β treated groups. Lipopolysaccharide (LPS) and TNF are
two upstream regulators shared by all groups at both 6 and 24 h.
In addition, IL-1β is common to all bacterial treatments at one
or both time points. It is noteworthy that the poly rI:rC-RNA, an
anti-viral response factor, was predicted to be uniquely activated
by BD at 6 h.
Regarding diseases and disorders associated with the datasets
of DEGs, inflammatory response and organismal injury and
abnormalities are shared by all treatments, though with different
numbers of focus molecules. For instance, the Islet Inflammatory
Response to EC was associated with activation of 248 and 160
molecules at 6 and 24 h, respectively. On the other hand, BD
Islet Inflammatory Response was associated with only 63 and
86 molecules at 6 and 24 h, respectively. RG treatment was
associated with 163 and 121 molecules at 6 and 24 h, respectively.
Such variation in number of genes associated with each bacteria
represents a scaling of the islet response toward the different
stimuli based on their unique molecular constituents.

IPA is a web-based application for analysis and interpretation
of data derived from different omics experiments, such as RNA
Sequencing and microarrays. It provides a powerful tool to
uncover the significance of data and identify new targets or
candidate biomarkers within the context of biological systems.
IPA core analysis is an advanced platform that allows for
pathway analysis, networking data, upstream effect analysis,
disease relationships, and functional analysis. Lists of DEGs
by all groups were submitted separately to IPA software for
core analysis. After that, all groups were compared using
comparison analysis. Islet treatment with bacteria and IL1β revealed modulation of 83 canonical pathways [z-score
≥2 (for activation) and ≤ −2 (for inhibition) and p-value
≤0.05 in the IPA software] (Supplementary Table 4). From this
list, we focused on those pathways related to the following
categories of Ingenuity Canonical Pathways: Cellular Immune
Response, Cytokine Signaling, Pathogen Influenced Signaling,
Cellular stress and Injury, Disease Specific Signaling and Toxicity
List Pathways (Figure 3). At the set threshold, eight signaling
pathways were commonly activated by all treatments at both 6
and 24 h (underlined in green in Figure 3). These pathways are
Neuroinflammation, IL-1, HMGB1, Dendritic Cell Maturation,
TREM1, Role of IL-17F in Allergic Inflammatory Airway
Diseases, MIF-mediated Glucocorticoid Regulation, and Th17
Activation. On the other hand, Role of Pattern Recognition
Receptors in Recognition of Bacteria and Viruses, Th2 signaling,
and p38 MAPK signaling pathways are highly activated by
bacteria, but not by IL-1β. Noteworthy, there was a preferential
activation of specific canonical pathways by either BD, RG, or
EC at 6 h (Supplementary Table 4). BD specifically upregulated
tRNA Charging, while RG exclusively activated NGF Signaling
and SPINK1 General Cancer Pathway. EC revealed a preferential
remarkable activation of Interferon Signaling, IL-3 Signaling and
Leukocyte Extravasation Signaling. Such preferential pathway
activation by certain treatments reflects the unique ability of the
islets to respond to distinct bacterial stimuli. It is also noteworthy
that T1D Signaling and Role of RIG1-like Receptors in Antiviral
Innate Immunity are clearly upregulated at 6 h by EC, RG, and
IL-1β, but not by BD.
Antioxidant action of Vitamin C is the only pathway
inhibited/downregulated at 6 h by all treatments. Inhibition of
the nuclear receptor LXR/RXR activation was evident in all
groups with more pronounced inhibition by BD and IL-Iβ at 24 h
and RG at both 6 and 24 h.

DEGs Common to All Treatments and
Those Unique to Each Bacteria
Due to similarities in the activation of important canonical
pathways, upstream regulators and disease associations among
different bacterial exposures, we next focused on DEGs
commonly expressed by each treatment at the two studied
time points. This latter set of molecules could help uncover
the intrinsic islet responses against invading bacteria and/or
their products. First, we analyzed genes co-regulated at both 6
and 24 h by each treatment, then compared subsequent lists of
intersected genes.
From the lists of downregulated genes, BD, EC, RG, and
IL-1β downregulated the expression of 12, 39, 29, and 163
genes at both 6 and 24 h (Figure 4A, Supplementary Table 5).
Further intersection of these genes revealed five genes universally
downregulated by all bacteria, as well as, IL-1β. These genes are
mainly enzymes, kinases, and receptors (Figures 4C,D, Table 2,
and Supplementary Table 6) such as EPHA4, MS4A6A, PRSS2,
OXGR1, and PLCE1.
In a similar way, from the lists of upregulated genes,
BD, EC, RG, and IL-1β upregulated the expression of 62,
167, 122, and 334 genes at both 6 and 24 h (Figure 4B,
Supplementary Table 5). Further intersection of these genes
revealed 47 genes universally upregulated by all bacteria as well as
IL-1β. These 47 genes are categorized as follows: 42.6% cytokines,
14.9% enzymes, 10.6% receptors, 8.5% transcription regulators,
6.4% transporters, 2% kinases, and 14.9% others (Figures 4E,F,
Table 2, and Supplementary Table 6). Commonly upregulated
cytokines and chemokines include several interleukins e.g., IL1A, IL-1B, IL-6, IL-7, and IL-23A; members of C-C motif
chemokines e.g., CCL2, CCL3, CCL4, and CCL20; members of
C-X-C motif chemokines e.g., CXCL1, CXCL2, CXCL6, and IL8 and NAMPT. Upregulated enzymes are as follows: ZC3H12A,
SOD2, PTGS2, BIRC3, TNFAIP3, and PLA2G4C. Upregulated
receptors are FFAR2 (free fatty acid receptor 2), PTAFR, ICAM1,
IL17RB, and IL7R. Transcription regulators are CEBPD, NFKBIA,
and RELB. Upregulated transporters are SLC30A2, SLC6A14,

Upstream Regulators, Diseases and Gene
Network Induced Bacteria, and IL-1β in
Human Islets
IPA core analysis including upstream effect, diseases, and
networks analyses were performed for all DEGs. The top
predicted upstream regulators, diseases, and in silico generated
networks are summarized in Table 1. Upstream effect analysis
is usually used to identify upstream factors that might drive the
expression of DEGs. Similarities were observed between bacteria
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TABLE 1 | Summary of top upstream regulators, diseases and disorders, and networks associated with exposure to bacteria or IL-1β at 6 and 24 h.
Experimental
condition

Top upstream regulators

Name

BD-6 h vs. SFC

BD-24 h vs. SFC

EC-6 h vs. SFC

EC-24 h vs. SFC

z-score p-value

Top diseases and disorders

Top networks

Name

p-value

No of focus
molecules

8.26E-32

51

LPS

8.4

4.27E-54

Cell death and survival

TNF

7.4

7.2E-49

Inflammatory response

1.03E-31

63

poly
rI:rC-RNA

6.7

1.02E-47

Cellular movement, immune cell
trafficking

2.63E-29

58

IL1β

6.9

1.79E-48

Dermatological diseases and
conditions

5.51E-33–9.61E-09

57

148

LPS

7.4

3.59E-44

Organismal injury and abnormalities

5.51E-33–3.22E-08

TNF

7.7

1.23E-43

Inflammatory response

4.84E-31–3.28E-08

86

TNF

11.7

6.04E-101

Inflammatory response

7.83E-58–8E-14

248

438

IL1β

9.9

1.63E-90

Organismal injury and abnormalities

7.83E-58–7.65E-14

LPS

11.3

2E-89

Cellular movement

2.77E-54–6.05E-14

202

IL1β

8.3

9.38E-66

inflammatory response

6.66E-41–1.8E-09

160

7
RG-6 h vs. SFC

RG-24 h vs. SFC

TNF

9.6

1.06E-63

Organismal injury and abnormalities

3.03E-40–2.15E-09

300

LPS

8.8

1.04E-61

Dermatological diseases and
conditions

6.31E-40–2.12E-09

89

TNF

9.8

1.72E-71

Inflammatory response

1.35E-48–1.7E-11

163

NFκB

8.7

1.33E-69

Organismal injury and abnormalities

2.77E-44–2.39E-11

292

LPS

10.4

2.27E-68

Hematological system development
and function

7.56E-44–2.55E-11

147

IL1β

8.1

1.55E-63

Inflammatory response

1.21E-41–5.64E-10

121

9.0

2.75E-58

Organismal injury and abnormalities

2.59E-36–6.11E-10

217

9.2

7.14E-56

Hematological system development
and function

9.1E-36–5.91E-10

113

IL1β

10.4

1.22E-97

Inflammatory response

1.64E-49–1.24E-13

331

TNF

13

1.17E-87

Cellular movement

2.3E-49–1.25E-13

330

LPS

11.8

1.77E-80

Immune cell trafficking

4.55E-48–1.25E-13

222

IL1β-24 h vs. SFC IL1β

9.5

3.4E-79

Inflammatory response

8.05E-48–4.06E-11

312

TNF

10.7

2.4E-75

Organismal injury and abnormalities

1.5E-47–4.43E-11

737

NFκB

8.3

1.79E-66

Cellular movement

6.19E-43–3.75E-11

290

IL1β-6 h vs. SFC

Score

No of focus
molecules

Hematological disease, immunological disease,
organismal injury and abnormalities

30

17

Cell-mediated immune response, cellular
development, cellular function and
maintenance

25

15

Inflammatory disease, cellular growth and
proliferation, lymphoid tissue structure and
development

36

24

Cellular development, cellular growth and
proliferation, hematological system
development and function

35

22

Humoral immune response, protein synthesis,
cell-to-cell signaling and interaction

31

20

Cellular development, cellular growth and
proliferation, connective tissue development
and function

29

18

Cell-to-cell signaling and interaction,
immunological disease, inflammatory disease

37

28

Cell morphology, cellular development, cellular
growth and proliferation

37

27
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FIGURE 4 | Shared differentially expressed genes (DEGs) specific to each tested bacterium after 6 and 24 h. (A) Venn diagrams indicating the overlap of
down-regulated genes at both 6 and 24 h in each group. (B) Venn diagrams indicating the overlap of up-regulated genes at both 6 and 24 h in each group.
(C) Intersection of down-regulated genes shared by each treatment. (D) Functional annotations of genes commonly down-regulated in all groups. (E) Intersection of
up-regulated genes shared by each treatment. (F) Functional annotations of genes commonly up-regulated in all groups.

NAMPT mRNA fold changes, as indicated by RNA-Seq, were
3.2 (6 h BD), 2.9 (24 h BD), 5.3 (6 h EC), 4.6 (24 h EC), 4.6
(6 h RG), 3.8 (24 h RG), 9.7 (6 h IL-1β), and 8.6 (24 h IL1β). With the exception of 6 h BD, a similar increase, though
at lower magnitude, in NAMPT protein expression was noted
(Figures 5A,B). SOD2 mRNA fold changes were 3.2 (6 h BD), 3.4
(24 h BD), 7.1 (6 h EC), 7.2 (24 h EC), 6.3 (6 h RG), 6.3 (24 h RG),
15 (6 h IL-1β), and 15.8 (24 h IL-1β). A corresponding increase
in all groups, though at lower magnitude than that observed for
RNA levels, in SOD2 protein expression was observed by western
blotting (Figures 5A,C). ACT1 mRNA fold changes were 1.6 (for
BD), 2.0 (6 h EC), 1.6 (24 h EC), 2.2 (6 h RG), 1.8 (24 h RG), 2.5
(6 h IL-1β), and 1.8 (24 h IL-1β). A corresponding increase, but
surprisingly at a higher magnitude, in ACT1 protein fold changes
was detected (Figures 5A,D).
The increase in the three aforementioned proteins was also
tested using biological replicates. Islets from another two donors
not used for RNA-Seq were initially treated with IL-1β and EC
for 24 h and subsequently further stressed with hyperglycemia.
At the end of exposure to bacteria or IL-1β, islets from IL1β, EC, and SFC were stimulated with 16 mM glucose for 4 h.
As shown in Figures 6A–D, NAMPT protein expression was
increased ∼9 and 6 times in IL-1β and EC treated groups
relative to controls. Similarly, ACT1 protein expression was
increased by ∼6 and 5.5-fold by IL-1β and EC treatments,
respectively. Notably, SOD2 protein expression was similar

and SLC7A11. IRAK2 (Interleukin 1 receptor associated kinase
2) is the only receptor kinase shared by all three bacteria
and IL-1β.
This analysis also revealed genes uniquely up- and
downregulated by each bacterium (Figures 4C,E). In this
regard, BD uniquely upregulated four genes (MTHFD2, ADM2,
ASNS, CHAC1) and downregulated three genes (SMAD9,
NXPH3, TGFB3). EC uniquely upregulated only one gene
(SLC7A5) and downregulated seven genes (SLCO2A1, FGL2,
GIMAP6, MIR143HG, CD300LB, HAVCR2, MSR1). Finally, RG
uniquely upregulated seven genes (ANO9, PLEKHG3, BBC3,
ATF3, RARRES3, PIM3, HAMP) and downregulated five genes
(LINC00473, TSIX, CSF1R, ELFN2, WNT16).
Next, we measured the protein expression of six factors
from the commonly upregulated genes using either western
blotting (islet lysates) or ELISAs (islet culture supernatants).
Lysates from one donor were immunoblotted using specific
antibodies against NAMPT, SOD2, and TRAF3-Interacting
Protein 2 (TRAF3IP2, also called ACT1). NAMPT and SOD2
are from the list of commonly upregulated factors (fold
change ≥ 2). TRAF3IP2 is an NF-κB activator commonly
upregulated by all treatments at a lower cut off (fold change
≥1.5). Additionally, protein concentrations of four cytokines,
within the list of commonly upregulated genes, namely
CCL20, CXCL1, CXCL6, and IL-8 were measured in islet
culture supernatant.
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TABLE 2 | Differentially expressed genes (DEGs) shared by all treatments at both 6 and 24 h.
Symbol

BD-6 h

BD-24 h

EC-6 h

EC-24 h

RG-6 h

RG-24 h

IL1β-6 h

IL1β-24 h

CYTOKINES/CHEMOKINES
IL6

6.1

5.6

17.5

13.3

11.6

8.4

60.7

46.7

CCL20

3.1

4.4

14.9

10.1

7.8

5.8

43.0

26.5

CXCL1

4.0

4.8

12.2

10.0

8.8

6.8

38.9

22.6

CXCL5

4.5

6.9

13.2

11.0

7.2

6.7

36.6

33.0

CSF2

6.2

7.7

14.4

5.8

10.9

7.4

35.2

4.4

CXCL8

5.8

6.6

14.0

12.3

11.1

9.2

33.7

20.1

IL7

4.8

3.1

10.7

6.5

11.1

6.3

30.6

13.6

CXCL3

3.5

4.2

9.5

6.2

7.1

4.7

29.7

12.4

CXCL2

3.7

4.2

8.3

7.5

8.2

5.8

28.6

13.4

CXCL6

2.5

4.1

7.3

8.9

5.2

5.2

20.4

29.7

IL1β

19.4

14.4

27.9

15.7

24.5

16.8

18.3

10.6

LIF

3.1

2.4

6.3

4.6

4.8

3.2

17.7

7.9

IL1A

4.5

3.6

12.6

6.0

6.4

3.9

15.1

5.4

NAMPT

3.2

2.9

5.3

4.6

4.6

3.8

9.7

8.6

IL23A

9.3

3.2

12.5

3.3

12.5

4.6

7.5

4.1

CSF1

2.4

2.0

4.4

2.9

3.8

2.9

7.1

4.3

TNFSF15

2.4

2.7

3.6

2.5

3.2

2.5

6.9

3.1

CCL2

2.2

2.1

3.5

2.2

3.0

2.0

4.6

3.0

CCL4

11.0

5.9

10.9

5.2

14.6

6.5

4.2

3.6

CCL3

15.4

12.9

17.6

10.2

20.5

14.6

4.2

4.9

ZC3H12A

2.7

3.0

5.0

5.3

5.5

4.6

15.6

11.1

SOD2

3.2

3.4

7.1

7.2

6.3

6.3

15.0

15.8

PTGS2

2.9

3.1

5.5

6.1

4.5

6.5

9.2

11.6

BIRC3

3.0

2.8

4.8

3.8

5.2

3.7

8.9

4.6

TNFAIP3

3.8

3.2

5.3

3.7

5.1

4.1

5.8

2.9

PLA2G4C

2.7

2.7

3.6

2.8

3.1

3.1

3.3

2.2

−2.3

−2.9

−3.9

−3.6

−2.6

−2.5

−6.3

−6.9

ENZYMES

PLCE1
MMP1

2.2

2.4

3.0

2.8

2.2

2.4

3.9

3.9

PRSS2

−3.0

−2.6

−4.3

−4.2

−2.7

−2.9

−4.3

−2.7

FFAR2

3.4

2.7

5.1

3.6

7.3

4.6

11.5

5.6

PTAFR

2.1

2.4

5.3

3.3

3.2

2.2

5.9

3.6

OXGR1

−2.4

−2.1

−2.9

−2.6

−2.9

−2.9

−5.2

−5.5

ICAM1

5.0

3.1

8.2

4.5

8.6

4.5

10.8

5.5

IL17RB

4.1

4.4

5.4

5.9

5.1

7.7

5.4

6.7

IL7R

3.0

2.2

5.9

3.2

4.5

2.2

5.3

4.3

RECEPTORS

KINASES
IRAK2

2.6

2.2

3.6

2.4

3.5

2.5

4.1

3.0

EPHA4

−2.3

−2.2

−2.7

−2.4

−2.8

−2.2

−2.7

−3.1

TRANSCRIPTIONAL REGULATORS
NFκBIA

4.6

3.4

6.5

4.5

7.0

4.9

10.6

6.2

CEBPD

2.4

2.2

3.9

3.8

4.2

3.2

8.1

6.5

NFκB2

6.1

3.1

7.1

3.3

7.3

3.7

7.3

3.6

RELB

4.9

2.8

5.3

2.9

5.6

3.3

4.5

2.4

SLC6A14

2.6

3.4

9.0

4.7

4.5

2.6

17.0

13.7

SLC30A2

2.8

3.4

3.3

4.6

4.6

7.0

6.3

8.9

SLC7A11

2.9

2.5

3.1

3.0

2.3

2.2

2.3

3.5

TRANSPORTERS

(Continued)
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TABLE 2 | Continued
Symbol

BD-6 h

BD-24 h

EC-6 h

EC-24 h

RG-6 h

RG-24 h

IL1β-6 h

IL1β-24 h

FGB

2.5

4.8

6.8

7.7

4.2

6.5

13.5

17.3

SNPH

2.5

2.8

4.9

6.2

6.2

7.0

12.1

9.9

SOCS1

3.3

2.6

6.7

5.3

5.4

3.7

11.9

11.3

TNFAIP2

2.4

2.1

4.5

2.6

3.7

2.1

6.5

2.7

NCCRP1

4.2

3.3

6.2

4.9

3.8

3.7

6.4

6.1

GRASP

2.2

2.1

2.8

2.5

2.9

3.1

3.0

3.1

NEAT1

2.1

2.1

2.1

2.4

2.5

2.5

3.0

3.0

−4.7

−5.4

−6.8

−8.6

−6.3

−4.9

−3.3

−3.4

OTHERS

MS4A6A

The color key indicates the direction of changes: red and green colors depict the fold changes of significant up- and down-regulated genes, respectively. Factors selected for validation
of RNA-Seq data using western blotting or ELISA are highlighted in bold.

FIGURE 5 | Protein expression levels for NAMPT, SOD2, and ACT1 was increased after islet incubation with bacteria and IL-1β. (A) Representative immunoblots for
three upregulated factors of interest; NAMPT, SOD2, and ACT1 from islet lysate of donor seven. (B–D) Except for NAMPT at 6 h treatment with BD, the three factors
revealed an overall increase in their expression at all-time points, compared to control islets. Data are shown as averages of fold changes relative to controls ±
standard deviations and are representative of three independent experiments.

DISCUSSION

between EC and IL-1β as it increased by 6.5 and 6.3 by IL-1β and
EC, respectively.
ELISA measurements of islet supernatants for IL-8, CXCL6, CXCL-1, and CCL20 levels revealed time dependent increases
by most treatments. These factors are known to increase during
islet inflammation and diabetes (26, 27). Such increases were
most pronounced by IL-1β (Figures 7A–D). However, only
IL-8 was consistently increased by all bacteria at both 6 and
24 h (Figure 7A).
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In the present study, human pancreatic islet responses to selected
bacteria overrepresented in the intestine of T1D subjects were
measured and compared in vitro. Ruminococcus gnavus (RG),
a Gram-positive bacterium and a pathobiont-like species (i.e.,
member of gut commensals that have the capacity to behave
as pathogens), showed a spike in relative abundance in T1Dsusceptible children concomitant with decreased diversity of
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FIGURE 6 | Increased protein expression levels for NAMPT, SOD2, and ACT1 in islets exposed to bacteria and IL-1β were maintained during subsequent
hyperglycemia. (A) Representative immunoblots for NAMPT, SOD2, and ACT1 from islet lysate of donors 3 and 4 challenged with 16 mM glucose for 4 h following
initial incubation with IL-1β or EC for 24 h. (B–D) The three factors revealed an overall increase in their expression in both treatments relative to control islets. Data are
shown as averages of fold changes relative to controls ± standard deviations and are representative of three independent experiments.

gut microbiome (15) was investigated in our study. Bacteroides
dorei (BD), a Gram-negative bacterium significantly elevated
in children becoming autoantibody positive (seroconverters)
compared to controls (non-converters) prior to the appearance of
the first islet autoantibody (14), was also included in our analysis.
Escherichia coli (EC) is another Gram-negative bacterium but
its abundance is not affected by gut dysbiosis. Since the latter
bacterium is known to elicit a potent immunostimulatory effect,
indicated by the release of proinflamatory cytokines from human
mononuclear cells exposed to its LPS (20), EC was used to
assess islet responses associated with BD and RG. IL-1β, a potent
inflammatory cytokine associated with islet failure in both types
of human diabetes (28, 29), served as a positive control.
Our RNA-Seq analysis of human islets exposed to selected
gut bacteria revealed alterations in gene expression levels at
both 6 and 24 h, with dominance in a number of DEGs
by EC (459 and 310, respectively) followed by RG (305 and
225, respectively) and BD (157 and 151, respectively). It is
noteworthy that the number of DEGs shared by each bacteria
with IL-1β followed the same pattern. Although the reasons
for such variation are largely unknown, the distinct structural
features among bacteria probably account for these differences.
Variation in the immunogenicity of LPS between EC and BD was
recently reported (20). In line with our findings, higher levels
of nuclear factor kappa B (NF-κB) induced cytokines e.g., IL-1β
and IL-6 were observed in human mononuclear cells following

Frontiers in Immunology | www.frontiersin.org

incubation with LPS from EC compared to BD. Surprisingly,
the increased production of the above mentioned cytokines by
EC was associated with lower rate of diabetes incidence (20).
Intraperitoneal (i.p.) injection of LPS from EC delayed the onset
of T1D in non-obese diabetic (NOD) mice, whereas BD LPS had
no effect (20). Moreover, splenocytes isolated from NOD mice
24 h following i.p. injection of EC LPS were less responsive to
further in vitro stimulation by bacterial endotoxins compared
to BD LPS (20). This suggests that continuous exposure to EC
LPS, but not BD LPS, contribute to prevention of autoimmunity
via increasing the host microbial tolerance. The distinct islet
antibacterial response to RG is likely due to cell wall constituents
such as peptidoglycans and lipoteichoic acid (30). Although the
mechanism is still unclear, peptidoglycans and lipoteichoic acid
are able to induce an inflammatory response comparable to
that induced by LPS via activation of host pattern recognition
receptors (31). This probably explains the shared features seen
between both gram positive (RG) and gram negative (BD, EC) in
the present study.

Unique BD-Mediated Effects on the Human
Islet Transcriptome
BD exposure led to unique changes in islet gene expression.
ADM2, ASNS, and CHAC1 were among the set of
genes preferentially upregulated by BD. ADM2 encodes
adrenomedullin 2, also called intermedin, a novel secreted
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FIGURE 7 | Changes in protein levels of selected cytokines in islets culture supernatant following incubation with bacteria and IL-1β. Selected cytokines included IL-8
(A), CXCL6 (B), CXCL1 (C), and CCL20 (D). Only IL-8 revealed significantly increased levels in all experimental treatments at both 6 and 24 h. Data are shown as
averages ± standard deviations (n ≥ 3 donors) and are representative of three independent experiments. *P < 0.05; ns, not significant.

peptide belonging to calcitonin family hormones (32), with
its expression being upregulated in different stress conditions
including endoplasmic reticulum (er) and oxidative stress
(33, 34). Interestingly, overexpression of ADM2 in mice
improved insulin sensitivity in adipocytes (35), suggesting
its role in metabolism. The upregulated expression of ASNS
by BD, which encodes asparagine synthetase, is known to
increase the production of asparagine (ASN). ASN contributes
to insulin secretion from pancreatic islets via accelerating
the rate of cytosolic NADPH generation (36), demonstrating
a metabolic role for ASNS. Interestingly, the released ASN
is also sensed by bacteria and modulates the expression of
nearly 17% of its genes increasing the rate of bacterial growth
(37). This suggests a role for ASN in mediating the symbiosis
between islets and bacteria. The exclusive activation of the tRNA
charging/loading pathway by BD exposure confirms its ability
to affect amino acid metabolism and protein synthesis. tRNA
charging/loading with amino acids is mediated by the enzyme
aminoacyl-tRNA synthetase that precedes mRNA translation
by ribosomes (38). CHAC1 encodes glutathione-specific
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gamma-glutamylcyclotransferase 1 that plays an important role
in glutathione metabolism and is associated with glutathione
depletion in stressed human islets (39). Glutathione contributes
to balancing the redox status of the islets and its deficiency
predisposes to diabetes (40–42). Additionally, CHAC1 expression
leads to increased inflammation during bacterial infection (43).
CHAC1 inhibition reduced il-6, il-8, and CCL2 secretion in cells
stimulated with LPS or flagellin (43), suggesting a role for CHAC1
in mediating tissue inflammation through controlling the release
of cytokines. Its upregulation would clearly be proinflammatory,
create insulitis and alter islet redox state. Genes encoding
TGF-β3 and SMAD9 were downregulated by BD. TGF-β
signaling regulates development, differentiation, and function
of pancreatic β-cells (44, 45). TGF-β3 has been also suggested
to play both immunomodulatory and anti-inflammatory roles
(46, 47). Interestingly, SMAD9 downregulation was evident in
transcriptomic profiling of isolated pancreatic islets from T1D
patients (48). In conclusion, our results suggest that BD exposure
uniquely affects insulin secretion, islet metabolic functions and
islet cell differentiation while promoting inflammation.
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Unique RG-Mediated Effects on the Human
Islet Transcriptome

known to affect hormone secretion in human and mouse
islets (66, 67). Although the biological relevance of the other
downregulated genes, OXGR1, PRSS2, MS4A6A, PLCE1, to T1D
is unknown, these factors might also have important roles
in the pancreas. For instance, Oxgr1 knockout mice revealed
inflammatory changes in the middle ear with a significant degree
of hearing loss, suggesting a role for OXGR1 in counteracting
inflammation (68).
Our comparison analysis using IPA software revealed 47 genes
upregulated by all bacteria and IL-1β. IL-1β transcription is
strongly induced by all the bacteria providing a basis for these
commonalities. These set of genes is dominated by cytokines
(20/47), enzymes (7/47), and receptors (5/47). IL-1β expression
is known to activate NF-kB pathway (69, 70), the increased
expression of transcripts for RelB and NF-kB2 (P52) subunits of
NF-kB observed in our RNA-Seq is most likely induced by islet
overexpression of IL-1β. Such activation of the NF-kB pathway
can have beneficial effects on cells (71). However, persistent
release of NF-kB dependent factors, including inflammatory
cytokines (e.g., IL-8, CXCL6, CXCL1, and CCL20), adhesion
molecules (e.g., ICAM1), G protein coupled receptors (e.g.,
FFAR2 or GPR43), enzymes (e.g., PTGS2 and TRAFIP3, or A20),
and matrix metallopeptidases (e.g., MMP1), could have very
deleterious effects on islets (72–74). IL-1R signaling plays an
important role during both diabetes progression and rejection
of islet grafts during transplantation by modulating IL-1β action
(75, 76). IRAK2, an enzyme that regulates IL-1β action (77),
was also found to be increased in our RNA-Seq analysis by all
groups. Such IRAK2 upregulation is probably associated with
sustained auto-stimulatory effects of IL-1β on islet cells (71).
It is noteworthy that, activation of NF-kB pathway was also
accompanied with NF-kBIA (NF-kB inhibitor α) upregulation
that was probably due to its continuous nucleocytoplasmic
shuttling to counteract the islet damage induced by NF-kB (78).
The release of four chemokines, namely IL-8, CXCL6, CXCL1,
and CCL20, known to be regulated by NF-kB activation was
partly confirmed using ELISA.
Our RNA-Seq analysis surprisingly revealed increased
expression of both IL-7 and IL-7R by all treatments. IL-7 is a
cytokine known to be expressed by stromal cells in lymphoid
tissues and bone marrow (79), but has never been reported
in islets. The cellular source of these factors in human islets
requires investigation.
It is noteworthy that SLC6A14 (Solute Carrier Family 6
Member 14) which encodes an l-arginine transporter protein,
was upregulated by all treatments. Islet exposure to Larginine is known to increase insulin secretion (80) again
suggesting bacterial influences on islet function. Exposure of
airway epithelia to bacterial flagellin led to upregulation of
SLC6A14 expression and increased uptake of L-arginine by
the cells (81). Moreover, inhibition of SLC6A14-dependent Larginine transport enhances bacterial attachment, suggesting an
additional role for SLC6A14 in islets via inhibiting bacterial
pathogenesis (81).
Upregulated expression of intracellular NAMPT, TRAF3IP2,
and SOD2 was confirmed at the protein level using western
blotting (Figures 5, 6). NAMPT encodes nicotinamide

RG exposure also resulted in unique gene expression changes.
BBC3 (BCL2 binding component 3) and ATF3 (activating
transcription factor 3) are two genes exclusively induced by
RG in human islets. Both BBC3 and ATF3 were reported to
play important roles in stress-induced β-cell apoptosis (49–
51). Interestingly, ATF3 upregulation was also found to mediate
protection against Gram-positive bacteria by enhancing cytokine
production during bacterial infection (52). In addition to
that, HAMP (a gene coding for hepcidin) was listed among
genes with increased expression in RG-treated islets. Hepcidin
is well known for its role in iron metabolism (53). It has
a known connection to the antimicrobial response as its
concentrations are increased following exposure to bacteria
(54). HAMP acts to starve bacteria of iron. Given that
hepcidin expression in the pancreas is exclusive to insulin
granules of islet β-cells (55), our analysis points to hepcidin
as a critical antimicrobial peptide upregulated during insulin
secretion. Iron also regulates different aspects of islet β cell
functions including glucose stimulated insulin secretion (56).
Wnt signaling plays a role in immunomodulation (57). The
Wnt family member WNT16 is exclusively downregulated
in islets by RG. Interestingly, WNT16 is downregulated in
several autoimmune diseases including lupus and arthritis
(58). Although earlier reports suggested abundant expression
in the pancreas (59), the specific cells expressing WNT16 in
the pancreas remains undefined. Notably, glucocorticoids are
known for their immunosuppressive properties and a dosedependent inhibition of WNT16 was reported in mouse bone
tissues following glucocorticoid treatment (60). Interestingly,
overexpression of WNT16 in mouse bone cells was able to revert
glucocorticoid-induced damage (60). Taken together, these data
point to WNT16 as an islet immunomodulator whose expression
is downregulated under stress conditions.

Bacteria-Specific Effects on the Human
Islet Transcriptome
BD, EC, and RG treated islets shared some features. From
the commonly upregulated list of cytokines/chemokines, three
factors revealed the highest increase in expression levels in
response to bacteria, especially RG, compared to IL-1β. These
factors are IL-23A, CCL3, and CCL4 (Table 2). A similar
induction of IL-23A, CCL3, and CCL4 by bacteria in other cell
types was reported (61–63), suggesting a major role for these
cytokines in antibacterial defense. The upregulated transcript
levels for IL-23A and CCL3 were found associated with high
incidence of autoimmunity (64). Conversely, the role of CCL4
during T1D appears to be protective (65).

Transcriptome Changes Shared by
All Treatments
Five genes were found to be commonly downregulated by all
bacteria and IL-1β exposure; OXGR1, PRSS2, MS4A6A, PLCE1,
and EPHA4. EPHA4 (EPH receptor A4) belongs to the proteintyrosine kinase family. Dysregulated EPH/ephrin signaling is
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phosphoribosyltransferase, a rate-limiting enzyme for NAD(+)
biosynthesis (82). NAMPT expression has been reported in
islet β-cells (83). Interestingly, NAMPT upregulation through
exogenous administration of nicotinamide mononucleotide
corrected islet damage induced by inflammatory cytokines IL-1β
and TNF-α (84), suggesting a protective role for NAMPT in
during islet stress. TRAF3IP2 is implicated in NF-kB activation
in many tissues during inflammation (85–87). SOD2 was
abundantly expressed in islets, as indicated by its signal intensity
in our immunoblots. Heterozygous deletion of SOD2 has been
shown to cause impaired insulin secretion in a mice model of
obesity (88).

pathway in our system. Upregulation of TREM1 signaling
pathway is associated with increased production of inflammatory
cytokines and possibly contributes to islet damage (90–92).
TREM1 upregulation was also noted to correlate with the severity
of bacterial infection via enhancing NF-κB pathway (93, 94).
The limitations of the present study should be acknowledged.
First, due to cost considerations, only eight human subjects were
tested. This might affect the reproducibility of data when larger
numbers of subjects are tested. Second, inclusion of commensal
gut species not associated with islet inflammation were not
evaluated. Thus, with the current design it is unclear whether
the reported responses were specific to the tested bacteria or
reflect a shared islet response to all bacteria. Third, other in
vivo factors contributing to complexity of islet response e.g.,
genetic susceptibility and signaling provided by islet juxtaposed
tissues are missing. Lastly, commercial bacterial strains from the
ATCC were used in this study. Recent reports have demonstrated
genomic variation and strain-specific functional adaptation of
gut bacteria in individuals with diseases (95, 96). Therefore,
bacteria isolated from diabetic individuals could induce a
different islet response.
In summary, our in vitro system uncovered key features of
the human islet response against invading gut bacteria and their
products (Figure 8). BD and RG uniquely influenced the human
islet transcriptome. These alterations would clearly affect islet
function and survival. Although direct role of bacteria in T1D
is under investigation, in the present study, proinflammatory
features such as cytokine and chemokine induction fit with the

Signaling Pathways Activated by Islets
Exposed to Bacteria
Our IPA core analysis confirmed the inflammatory nature of the
islet antibacterial response. In line with increased IL-1β mRNA
in our RNA-Seq DEGs, IL-1 signaling was found among the
top canonical pathways upregulated by all treatments. Another
upregulated pathway is the intracellular accumulation of nitric
oxide synthase (NOS) which is associated with mitochondrial
dysfunction and correlates with the severity of islet inflammation
(89). The inflammatory response pathway was the top disease
category altered by bacteria and cytokine treatment in our IPA
functional analysis. The comparatively limited inflammatory
response induced by BD complements our knowledge about
its weak immunostimulatory effects (20). TREM1 (triggering
receptor on myeloid cells 1) is the topmost activated canonical

FIGURE 8 | Schematic representation of human islet response against T1D-associated bacteria. Gut bacteria traverse the damaged gut barrier and reach the
pancreas. Upon reaching the pancreatic islets, bacteria elicit islet response via several pathways including activation of antimicrobial response factors, increased
production of cytokines and chemokines, activation of TREM1 signaling, increased oxidative stress levels and enhanced amino acid synthesis. The activated
pathways contribute to both islet damage and microbial survival which ultimately cause islet inflammation and increase the severity of autoimmunity.
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observation of infiltrating immune cells into islets in human T1D.
Future mechanistic studies involving in vivo models are needed
to link these changes to T1D pathogenesis.
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